These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

777 related articles for article (PubMed ID: 27926730)

  • 1. Integrin-YAP/TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flow.
    Wang L; Luo JY; Li B; Tian XY; Chen LJ; Huang Y; Liu J; Deng D; Lau CW; Wan S; Ai D; Mak KK; Tong KK; Kwan KM; Wang N; Chiu JJ; Zhu Y; Huang Y
    Nature; 2016 Dec; 540(7634):579-582. PubMed ID: 27926730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow-dependent YAP/TAZ activities regulate endothelial phenotypes and atherosclerosis.
    Wang KC; Yeh YT; Nguyen P; Limqueco E; Lopez J; Thorossian S; Guan KL; Li YJ; Chien S
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11525-11530. PubMed ID: 27671657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atheroprotective effects of methotrexate via the inhibition of YAP/TAZ under disturbed flow.
    Liu D; Lv H; Liu Q; Sun Y; Hou S; Zhang L; Yang M; Han B; Wang G; Wang X; Du W; Nie H; Zhang R; Huang X; Hou J; Yu B
    J Transl Med; 2019 Nov; 17(1):378. PubMed ID: 31730006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laminar flow inhibits the Hippo/YAP pathway via autophagy and SIRT1-mediated deacetylation against atherosclerosis.
    Yuan P; Hu Q; He X; Long Y; Song X; Wu F; He Y; Zhou X
    Cell Death Dis; 2020 Feb; 11(2):141. PubMed ID: 32081881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvianolic acid B ameliorates atherosclerosis via inhibiting YAP/TAZ/JNK signaling pathway in endothelial cells and pericytes.
    Yang Y; Pei K; Zhang Q; Wang D; Feng H; Du Z; Zhang C; Gao Z; Yang W; Wu J; Li Y
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Oct; 1865(10):158779. PubMed ID: 32739616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomimetic nanodrug targets inflammation and suppresses YAP/TAZ to ameliorate atherosclerosis.
    Huang HC; Wang TY; Rousseau J; Orlando M; Mungaray M; Michaud C; Plaisier C; Chen ZB; Wang KC
    Biomaterials; 2024 Apr; 306():122505. PubMed ID: 38359507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piezo1 mediates endothelial atherogenic inflammatory responses via regulation of YAP/TAZ activation.
    Yang Y; Wang D; Zhang C; Yang W; Li C; Gao Z; Pei K; Li Y
    Hum Cell; 2022 Jan; 35(1):51-62. PubMed ID: 34606042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
    Juan WC; Hong W
    Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Yes-Associated Protein/PDZ-Binding Motif Pathway Contributes to Endothelial Dysfunction and Vascular Inflammation in AngiotensinII Hypertension.
    Xu Q; Zhuo K; Cai R; Su X; Zhang L; Liu Y; Zhu L; Ren F; Zhou MS
    Front Physiol; 2021; 12():732084. PubMed ID: 34650444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of mechanotransduction via YAP/TAZ in animal epithelia.
    Elbediwy A; Thompson BJ
    Curr Opin Cell Biol; 2018 Apr; 51():117-123. PubMed ID: 29477107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinctive Roles of YAP and TAZ in Human Endothelial Progenitor Cells Growth and Functions.
    Klaihmon P; Lorthongpanich C; Kheolamai P; Luanpitpong S; Issaragrisil S
    Biomedicines; 2022 Jan; 10(1):. PubMed ID: 35052826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between Keloid Formation and YAP/TAZ Signaling.
    Aramaki-Hattori N; Okabe K; Hamada M; Takato T; Kishi K
    Plast Reconstr Surg Glob Open; 2017 Jun; 5(6):e1357. PubMed ID: 28740772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YAP/TAZ: a promising target for squamous cell carcinoma treatment.
    Dong X; Meng L; Liu P; Ji R; Su X; Xin Y; Jiang X
    Cancer Manag Res; 2019; 11():6245-6252. PubMed ID: 31360073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YAP/TAZ interacts with RBM39 to confer resistance against indisulam.
    Ando T; Okamoto K; Ueda Y; Kataoka N; Shintani T; Yanamoto S; Miyauchi M; Kajiya M
    Oncogenesis; 2024 Jul; 13(1):25. PubMed ID: 39004623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The regulation of yes-associated protein/transcriptional coactivator with PDZ-binding motif and their roles in vascular endothelium.
    Zhang W; Li QQ; Gao HY; Wang YC; Cheng M; Wang YX
    Front Cardiovasc Med; 2022; 9():925254. PubMed ID: 35935626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lesion-specific suppression of YAP/TAZ by biomimetic nanodrug ameliorates atherosclerosis development.
    Huang HC; Wang TY; Rousseau J; Mungaray M; Michaud C; Plaisier C; Chen ZB; Wang KC
    bioRxiv; 2023 Apr; ():. PubMed ID: 37163067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yes-associated protein (YAP) and transcriptional coactivator with a PDZ-binding motif (TAZ): a nexus between hypoxia and cancer.
    Zhao C; Zeng C; Ye S; Dai X; He Q; Yang B; Zhu H
    Acta Pharm Sin B; 2020 Jun; 10(6):947-960. PubMed ID: 32642404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AR activates YAP/TAZ differentially in prostate cancer.
    Salem O; Jia S; Qian BZ; Hansen CG
    Life Sci Alliance; 2023 Sep; 6(9):. PubMed ID: 37385752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecules inhibiting the nuclear localization of YAP/TAZ for chemotherapeutics and chemosensitizers against breast cancers.
    Oku Y; Nishiya N; Shito T; Yamamoto R; Yamamoto Y; Oyama C; Uehara Y
    FEBS Open Bio; 2015; 5():542-9. PubMed ID: 26199863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of Hippo-YAP/TAZ signaling pathway in mechanotransduction.].
    Ishihara E; Nishina H
    Clin Calcium; 2016; 26(12):1751-1756. PubMed ID: 27885187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.